FDA 510(k)

ARK 甲氨蝶呤II测定法

K号: K232017 · 2023-12-20

决定日期2023-12-20

产品代码LAO

决定实质等同

器械摘要

ARK Methotrexate II Assay is the device name listed in this FDA 510(k) record. The listed applicant is Ark Diagnostics, Inc.. It received FDA 510(k) clearance on 2023-12-20 under 510(k) number K232017. The device is classified under product code LAO. FDA Decision: Substantially Equivalent.

常见问题

What is the ARK Methotrexate II Assay?

ARK Methotrexate II Assay is a medical device that received FDA 510(k) clearance on 2023-12-20. The listed applicant is Ark Diagnostics, Inc.. The 510(k) number is K232017.

When did ARK Methotrexate II Assay receive FDA 510(k) clearance?

ARK Methotrexate II Assay received FDA 510(k) clearance on 2023-12-20, under 510(k) number K232017.

Who is the listed applicant for ARK Methotrexate II Assay?

The FDA 510(k) record lists Ark Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ARK Methotrexate II Assay?

The FDA product code for ARK Methotrexate II Assay is LAO.

列明Ark Diagnostics, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K232522ARK 左乙拉西坦II测定法 K231752ARK 氢可酮测定法 K201089ARK 拉考沙胺测定法 K200197ARK 芬太尼II测定法 K182280ARK 曲马多检测 K182779ARK EDDP 测定法

查看所有 10 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。